LK
Lori Anne Kunkel

Lori Anne Kunkel insider trades: Enliven Therapeutics (ELVN) stock sales

Enliven Therapeutics Last trade Jul 6, 2026 50 Form 4 filings
$850K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2017
7
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Lori reports to the SEC

and 1 more company

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 6, 2026ELVN↓ Sell$505K
Jun 5, 2026ELVN↓ Sell$345K
Jan 23, 2019CRIS↓ Sell$16K
Oct 1, 2018LOXO↓ Sell$852K
Jun 15, 2018LOXO↓ Sell$7.1M
Apr 20, 2018LOXO↓ Sell$663K
Nov 2, 2017LOXO↓ Sell$425K
Aug 22, 2017LOXO↓ Sell$752K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ELVN insiders

Open-market trades in the last 12 months

About Lori Anne Kunkel's insider trades

Lori Anne Kunkel is an insider at Enliven Therapeutics (ELVN). Since Aug 22, 2017, Lori has reported no open-market purchases and 8 sales worth $10.6M on SEC Form 4. In the last 12 months: 2 sales ($850K).

Their filings also include grants and awards (32 filings), option exercises (8 filings), other transactions (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELVN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.